CTNNB1 Gene Mental Retardation Autosomal Dominant Type 19 NGS Genetic DNA Test
Introduction
The CTNNB1 Gene Mental Retardation Autosomal Dominant Type 19 NGS Genetic DNA Test is a cutting-edge diagnostic tool designed to identify mutations in the CTNNB1 gene associated with neurological disorders. This test is vital for families with a history of mental retardation, providing crucial insights that can guide treatment and management options.
What the Test Measures
This test specifically detects mutations in the CTNNB1 gene, which plays a significant role in brain development and function. By utilizing Next-Generation Sequencing (NGS) technology, the test analyzes genetic material to identify potential abnormalities that may contribute to neurological disorders.
Who Should Consider This Test
Individuals who should consider the CTNNB1 Gene test include:
- Patients exhibiting symptoms of mental retardation or developmental delays.
- Families with a history of neurological disorders.
- Individuals with a clinical diagnosis suggesting genetic causes.
Benefits of Taking the Test
Taking the CTNNB1 Gene test offers several benefits:
- Accurate diagnosis of genetic conditions related to neurological disorders.
- Informed decision-making for treatment and management options.
- Potential for targeted therapies based on genetic findings.
- Peace of mind for families regarding genetic risks.
Understanding Your Results
Once the test is completed, results will be provided to you in a comprehensive report. It is essential to discuss these results with a healthcare professional, preferably a neurologist or genetic counselor, to understand their implications fully.
Test Pricing
| Price Type | Amount (NGN) |
|---|---|
| Discount Price | 400,000 |
| Regular Price | 560,000 |
Book Your Test Today
To book the CTNNB1 Gene Mental Retardation Autosomal Dominant Type 19 NGS Genetic DNA Test, please contact us at +2348077798758. Our team is ready to assist you with any questions and guide you through the booking process.
Turnaround time for results is approximately 3 to 4 weeks, and the sample type required is either blood or extracted DNA, or one drop of blood on an FTA card. Prior to the test, a genetic counseling session is recommended to discuss family history and draw a pedigree chart of affected family members.
